The most severe NAFLD modifiers are transmembrane 6 superfamily member 2 (TM6SF2) p.E167K and the rs641738 membrane bound-o-acyltransferase domain-containing 7 (MBOAT7) polymorphisms [84]. Here, MBOAT7 is linked to metabolic dysfunction-associated steatotic liver disease.